Asian Spectator

The Times Real Estate

.

Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World

  • Written by PR Newswire Asia - Asian Spectator
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World
  • Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America.
  • Jiangsu Alphamab and 3D Medicines will receive a low double digit Million US Dollar amount up to launch, additional triple digit Million US Dollar milestone payments based...

Magazine

Gerakan “rimpang”: Bagaimana kaum muda jatuh bangun bergerak melawan rezim

Mahasiswa berdemonstrasi menentang kebijakan pemerintah di sekitar kompleks gedung DPR/MPR RI di Senayan, Jakarta, pada 22 Agustus 2024.ahmad16firdaus/Shutterstock● Gerakan kaum muda semakin mas...

Berencana tambah anak? Ini tips agar si kakak tak merasa kurang kasih sayang

Helping your older child or children navigate having a new sibling will help set the stage for positive sibling relationships across childhood and beyond.(Colourbox)Menantikan anak kedua (atau selanju...

Zodiak, MBTI, dan tarot: Mengapa sebagian kaum muda percaya pseudosains

● Banyak kaum muda yang percaya zodiak dan bentuk-bentuk pseudosains lainnya.● Meski tak ilmiah, pseudosains menawarkan narasi personal yang nyaman dan mudah dipahami.● Jika tidak di...